XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements
6 Months Ended
Jun. 30, 2025
Fair Value Measurements  
Fair Value Measurements

NOTE 12 — Fair Value Measurements

Derivative Instruments: Derivative instruments that are not traded on an exchange are valued using conventional calculations/models that are primarily based on unobservable inputs such as private company unit price and volatilities, and therefore, such derivative instruments are included in Level 3.

Warrant Liabilities: Warrant liabilities that are not traded on an exchange are valued using conventional calculations/models that are primarily based on unobservable inputs such as private company unit price and volatilities, and therefore, such warrant instruments are included in Level 3.

Earn-out Liability: Earn-out liability is derived from inputs that are unobservable and valued using conventional calculations/models that utilizes key assumptions including forecasted revenues and volatilities of the underlying financial metrics during the Earnout period, and therefore, such instrument is included in Level 3.

Upon the completion of the Business Combination, all outstanding warrants and options were exercised and converted into shares of the Company’s common stock, with the exception of the options related to Seaport’s second bridge loan, which were exercised on January 7, 2025. On March 31, 2025, the Company entered into an amendment to its bridge loan agreements with Seaport Group SIBS LLC. Under the terms of the amendment, Seaport agreed to convert the cumulative principal and accrued interest from the first and second bridge loans, purchase order loans, and OPG loans into 5,350,000 shares of the Company’s common stock. Additionally, in the same amendment, the Company granted Seaport a warrant to purchase 3,000,000 shares of common stock at an exercise price of $0.01 per share. Seaport exercised the warrant on March 31, 2025 by remitting $30,000, and the 3,000,000 shares of common stock were subsequently issued on April 2, 2025.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024, respectively, and indicates the fair value hierarchy of the valuation inputs the Company utilized.

Description

    

Level

    

June 30, 2025

    

December 31, 2024

Liabilities

Warrant liabilities

 

3

$

$

16,241,092

Derivative liabilities

 

3

$

$

8,327,602

Earn-out liability

3

$

13,000

$

The Company determined that the warrants, as of December 31, 2024, associated with notes are subject to treatment as a liability as the warrants for units of the Legacy Company are not indexed to its own membership interests. The warrants were subject to remeasurement at each balance sheets date and any change in fair value is recognized as a component of other expenses on the condensed consolidated statements of operations.

The following tables present information about the change in fair value of the Company’s Level 3 warrant liabilities and derivative liabilities for the three and six months ended June 30, 2025.

Three months ended

Six months ended

Warrant liabilities

    

June 30, 2025

    

June 30, 2025

Fair value - beginning of period

 

$

 

$

16,241,092

Issuance

Warrant exercised

(16,017,930)

Change in fair value

(223,162)

Fair value - end of period

 

$

 

$

Three months ended

Six months ended

Derivative liabilities

    

June 30, 2025

    

June 30, 2025

Fair value - beginning of period

$

$

8,327,602

Issuance

 

 

Option exercised

(9,155,047)

Change in fair value

 

 

827,445

Fair value - end of period

$

$

Three months ended

Six months ended

Earn-out liabilities

    

June 30, 2025

    

June 30, 2025

Fair value - beginning of period

$

30,000

$

Issuance

 

30,000

Change in fair value

(17,000)

 

(17,000)

Fair value - end of period

$

13,000

$

13,000